AURAAura Biosciences, Inc.
What is the market doing?
No clear lean: rangebound and heavily shorted.
Rangebound, no clear trend. Price is −6% vs its 200-day average.
Heavily shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AURA is trading
Aura Biosciences, Inc. is +9.0% over the past year while the S&P 500 is +16%: 7.0 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −6.1%
vs 200-day average · below trend, but not far
- RSI (14)
- 51
RSI (14) · neutral
- Below its 52-week high
- 29%
Below its 52-week high
Details›
- Last close2026-10-23
- $6.28
- 1 monthS&P 500 −0.94%
- +1.9%
- 1 yearS&P 500 +16%
- +9.0%
- vs 50-day average$6.84
- −8.1%
- 52-week high
- $8.90
- 52-week low
- $4.97
- Annualised volatility
- 57%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $39M
| Year | Return |
|---|---|
| 2026 (year to date) | +15% |
| 2025 | −34% |
| 2024 | −7.2% |
| 2023 | −16% |
| 2022 | −38% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 5 | 2 of 5 | −1.6% |
| Feb | 5 | 2 of 5 | +2.5% |
| Mar | 5 | 2 of 5 | −1.2% |
| Apr | 5 | 1 of 5 | −5.3% |
| May | 5 | 4 of 5 | +6.8% |
| Jun | 5 | 3 of 5 | −1.00% |
| Jul | 5 | 3 of 5 | +8.2% |
| Aug | 5 | 1 of 5 | −9.6% |
| Sep | 5 | 2 of 5 | +4.1% |
| Oct | 5 | 1 of 5 | −4.9% |
| Nov | 5 | 3 of 5 | +5.6% |
| Dec | 5 | 1 of 5 | −9.6% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.